| Feb 12, 2026 |
Feb 13, 2026 |
Dahms Bradford D.
|
CFO |
Neutral |
90.0
|
+37,813
|
100.00%
|
✗
|
- |
| Feb 12, 2026 |
Feb 13, 2026 |
Balta Elizabeth
|
Officer |
Neutral |
90.0
|
+28,125
|
100.00%
|
✗
|
- |
| Feb 12, 2026 |
Feb 13, 2026 |
Frohlich Tom
|
CEO |
Neutral |
90.0
|
+78,750
|
1038.78%
|
✗
|
- |
| Feb 12, 2026 |
Feb 13, 2026 |
King Andrew James
|
Officer |
Neutral |
90.0
|
+41,250
|
11.96%
|
✗
|
- |
| Oct 6, 2025 |
Oct 8, 2025 |
Fairmount Funds Management LLC
|
Director |
Neutral |
90.0
|
+1,333,126
|
41.40%
|
✗
|
- |
| Jul 14, 2025 |
Jul 14, 2025 |
Dahms Bradford D.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 14, 2025 |
Dahms Bradford D.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 16, 2025 |
May 19, 2025 |
Frohlich Tom
|
CEO |
Buy |
91.3
|
+6,000
|
100.00%
|
✗
|
$44.4K |
| Apr 29, 2025 |
May 1, 2025 |
Fairmount Funds Management LLC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 29, 2025 |
May 1, 2025 |
Lavelle Erin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 29, 2025 |
May 1, 2025 |
Klein Lawrence Otto
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 29, 2025 |
May 1, 2025 |
CAIN CHRISTOPHER W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 29, 2025 |
May 1, 2025 |
DOBMEIER ERIC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 1, 2025 |
Fairmount Funds Management LLC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 1, 2025 |
Lavelle Erin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 1, 2025 |
Klein Lawrence Otto
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 1, 2025 |
CAIN CHRISTOPHER W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 1, 2025 |
DOBMEIER ERIC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 1, 2025 |
Balta Elizabeth
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 1, 2025 |
Kocinsky Hetal
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 1, 2025 |
King Andrew James
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 1, 2025 |
Quick Jonathan
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 1, 2025 |
Frohlich Tom
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 28, 2025 |
Apr 30, 2025 |
RA CAPITAL MANAGEMENT, L.P.
|
10% Owner |
Neutral |
90.0
|
+1,062,326
|
471.03%
|
✗
|
- |
| Jul 31, 2024 |
Aug 2, 2024 |
Dake Benjamin T
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2024 |
Jun 20, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Buy |
100.0
|
+928,110
|
13.32%
|
✗
|
$1.5M |
| Jun 14, 2024 |
Jun 14, 2024 |
Eldridge George A
|
Officer |
Sell |
7.5
|
-15,000
|
-74.92%
|
✓
|
$375.5K |
| Jun 14, 2024 |
Jun 14, 2024 |
Verwijs Marinus
|
CHIEF TECHNICAL OFFICER |
Sell |
7.5
|
-10,600
|
-100.00%
|
✓
|
$265K |
| Jun 13, 2024 |
Jun 14, 2024 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-6,000
|
-51.72%
|
✓
|
$147K |
| Jun 5, 2024 |
Jun 7, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Santel Donald J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Resnick Joshua
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Katabi Maha
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Iwicki Mark T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
GRAYZEL DAVID S.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Dable Habib J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Dorval Allison
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 17, 2024 |
May 17, 2024 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-4,000
|
-41.66%
|
✓
|
$84.3K |
| May 16, 2024 |
May 17, 2024 |
NOYES TIMOTHY P
|
CEO |
Sell |
10.0
|
-10,000
|
-100.00%
|
✓
|
$215.8K |
| May 2, 2024 |
May 3, 2024 |
Verwijs Marinus
|
CHIEF TECHNICAL OFFICER |
Sell |
26.3
|
-1,981
|
-100.00%
|
✗
|
$41.6K |
| May 1, 2024 |
May 3, 2024 |
NOYES TIMOTHY P
|
CEO |
Sell |
10.0
|
-11,357
|
-92.17%
|
✓
|
$230.9K |
| Apr 17, 2024 |
Apr 19, 2024 |
Dake Benjamin T
|
Officer |
Sell |
10.0
|
-6,853
|
-84.15%
|
✓
|
$153.3K |
| Apr 17, 2024 |
Apr 19, 2024 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-4,000
|
-55.16%
|
✓
|
$89.5K |
| Apr 16, 2024 |
Apr 18, 2024 |
NOYES TIMOTHY P
|
CEO |
Sell |
10.0
|
-10,000
|
-100.00%
|
✓
|
$247K |
| Apr 10, 2024 |
Apr 12, 2024 |
Eldridge George A
|
Officer |
Sell |
10.0
|
-7,500
|
-79.28%
|
✓
|
$201.4K |
| Apr 9, 2024 |
Apr 11, 2024 |
GRAYZEL DAVID S.
|
Director |
Sell |
30.0
|
-11,882
|
-0.66%
|
✗
|
$334.5K |
| Apr 1, 2024 |
Apr 3, 2024 |
NOYES TIMOTHY P
|
CEO |
Sell |
7.5
|
-10,000
|
-100.00%
|
✓
|
$300K |
| Apr 1, 2024 |
Apr 3, 2024 |
Dake Benjamin T
|
Officer |
Sell |
10.0
|
-3,325
|
-72.03%
|
✓
|
$106.3K |
| Apr 1, 2024 |
Apr 3, 2024 |
Verwijs Marinus
|
CHIEF TECHNICAL OFFICER |
Sell |
10.0
|
-5,300
|
-100.00%
|
✓
|
$154.7K |
| Apr 1, 2024 |
Apr 3, 2024 |
Eldridge George A
|
Officer |
Sell |
7.5
|
-12,495
|
-86.44%
|
✓
|
$390.2K |
| Mar 28, 2024 |
Apr 1, 2024 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
7.5
|
-9,000
|
-73.46%
|
✓
|
$265.5K |
| Mar 27, 2024 |
Mar 28, 2024 |
Dake Benjamin T
|
Officer |
Sell |
7.5
|
-11,068
|
-89.55%
|
✓
|
$309.5K |
| Mar 25, 2024 |
Mar 27, 2024 |
Dake Benjamin T
|
Officer |
Sell |
10.0
|
-3,432
|
-72.67%
|
✓
|
$96.1K |
| Mar 19, 2024 |
Mar 20, 2024 |
Verwijs Marinus
|
CHIEF TECHNICAL OFFICER |
Sell |
10.0
|
-5,300
|
-100.00%
|
✓
|
$138.2K |
| Mar 18, 2024 |
Mar 20, 2024 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-7,000
|
-68.29%
|
✓
|
$181.1K |
| Mar 18, 2024 |
Mar 20, 2024 |
Dake Benjamin T
|
Officer |
Sell |
7.5
|
-35,057
|
-96.45%
|
✓
|
$908K |
| Mar 12, 2024 |
Mar 14, 2024 |
Eldridge George A
|
Officer |
Sell |
10.0
|
-4,067
|
-50.92%
|
✓
|
$101.8K |
| Mar 7, 2024 |
Mar 11, 2024 |
Eldridge George A
|
Officer |
Sell |
7.5
|
-25,933
|
-76.76%
|
✓
|
$649.2K |
| Mar 7, 2024 |
Mar 11, 2024 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-8,975
|
-73.41%
|
✓
|
$219.9K |
| Mar 4, 2024 |
Mar 6, 2024 |
Dable Habib J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 23, 2024 |
Feb 27, 2024 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
30.0
|
-511
|
-13.58%
|
✓
|
$10K |
| Feb 20, 2024 |
Feb 22, 2024 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-3,489
|
-51.77%
|
✓
|
$70.6K |
| Feb 5, 2024 |
Feb 7, 2024 |
NIVEN RALPH
|
CHIEF SCIENTIFIC OFFICER |
Sell |
10.0
|
-4,600
|
-74.09%
|
✓
|
$80.2K |
| Jan 29, 2024 |
Jan 31, 2024 |
NOYES TIMOTHY P
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2024 |
Jan 24, 2024 |
Pigot Timothy
|
CHIEF COMMERCIAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2024 |
Jan 24, 2024 |
Verwijs Marinus
|
CHIEF TECHNOLOGY OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2024 |
Jan 24, 2024 |
NIVEN RALPH
|
CHIEF SCIENTIFIC OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2024 |
Jan 24, 2024 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2024 |
Jan 24, 2024 |
Dake Benjamin T
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2024 |
Jan 24, 2024 |
Eldridge George A
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 17, 2024 |
Jan 19, 2024 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-4,000
|
-55.16%
|
✓
|
$78K |
| Jan 5, 2024 |
Jan 8, 2024 |
NIVEN RALPH
|
CHIEF SCIENTIFIC OFFICER |
Sell |
10.0
|
-4,600
|
-74.09%
|
✓
|
$88.1K |
| Jan 2, 2024 |
Jan 4, 2024 |
Santel Donald J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2024 |
Jan 4, 2024 |
Dable Habib J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2024 |
Jan 4, 2024 |
Katabi Maha
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2024 |
Jan 4, 2024 |
GRAYZEL DAVID S.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 27, 2023 |
Dec 29, 2023 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
42.5
|
-125
|
-3.70%
|
✓
|
$3.1K |
| Dec 13, 2023 |
Dec 22, 2023 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-4,000
|
-55.16%
|
✓
|
$78K |
| Dec 13, 2023 |
Dec 15, 2023 |
Gillies Hunter
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-12,000
|
-64.86%
|
✓
|
$234K |
| Dec 5, 2023 |
Dec 7, 2023 |
NIVEN RALPH
|
CHIEF SCIENTIFIC OFFICER |
Sell |
10.0
|
-4,600
|
-74.09%
|
✓
|
$75K |
| Dec 6, 2023 |
Dec 7, 2023 |
Dake Benjamin T
|
Officer |
Sell |
10.0
|
-10,283
|
-88.85%
|
✓
|
$165.6K |
| Nov 27, 2023 |
Nov 29, 2023 |
Dake Benjamin T
|
Officer |
Sell |
10.0
|
-12,517
|
-90.65%
|
✓
|
$203.2K |
| Nov 22, 2023 |
Nov 27, 2023 |
Dake Benjamin T
|
Officer |
Sell |
10.0
|
-14,372
|
-78.47%
|
✓
|
$220.9K |
| Nov 22, 2023 |
Nov 27, 2023 |
NIVEN RALPH
|
CHIEF SCIENTIFIC OFFICER |
Sell |
10.0
|
-13,800
|
-89.56%
|
✓
|
$207K |
| Nov 1, 2023 |
Nov 3, 2023 |
Verwijs Marinus
|
CHIEF TECHNOLOGY OFFICER |
Sell |
26.3
|
-970
|
-100.00%
|
✗
|
$10.1K |
| Nov 1, 2023 |
Nov 3, 2023 |
NOYES TIMOTHY P
|
CEO |
Sell |
13.8
|
-1,092
|
-100.00%
|
✓
|
$11.4K |
| Sep 6, 2023 |
Sep 8, 2023 |
Dake Benjamin T
|
Officer |
Sell |
10.0
|
-3,961
|
-60.54%
|
✓
|
$59.6K |
| Aug 7, 2023 |
Aug 9, 2023 |
Dake Benjamin T
|
Officer |
Sell |
10.0
|
-10,283
|
-88.85%
|
✓
|
$159.6K |
| Jul 28, 2023 |
Aug 1, 2023 |
NOYES TIMOTHY P
|
CEO |
Sell |
10.0
|
-5,478
|
-100.00%
|
✓
|
$98.6K |
| Jul 17, 2023 |
Jul 19, 2023 |
NOYES TIMOTHY P
|
CEO |
Sell |
10.0
|
-4,522
|
-100.00%
|
✓
|
$81.9K |
| Jul 10, 2023 |
Jul 11, 2023 |
Dable Habib J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 11, 2023 |
Dable Habib J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 6, 2023 |
Jul 7, 2023 |
Dake Benjamin T
|
Officer |
Sell |
10.0
|
-10,283
|
-88.85%
|
✓
|
$171.3K |
| Jul 5, 2023 |
Jul 7, 2023 |
NIVEN RALPH
|
CHIEF SCIENTIFIC OFFICER |
Sell |
13.8
|
-2,250
|
-58.31%
|
✓
|
$38.9K |
| Jul 3, 2023 |
Jul 5, 2023 |
NOYES TIMOTHY P
|
CEO |
Sell |
10.0
|
-10,000
|
-100.00%
|
✓
|
$180K |
| Jun 6, 2023 |
Jun 8, 2023 |
RA CAPITAL MANAGEMENT, L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2023 |
Jun 8, 2023 |
Dake Benjamin T
|
Officer |
Sell |
10.0
|
-10,283
|
-88.85%
|
✓
|
$167.4K |
| Jun 6, 2023 |
Jun 8, 2023 |
Santel Donald J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2023 |
Jun 8, 2023 |
Katabi Maha
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2023 |
Jun 8, 2023 |
GRAYZEL DAVID S.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |